SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-046022
Filing Date
2024-04-19
Accepted
2024-04-19 16:20:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A updated_beam_2024_notice.htm DEFA14A 29953
2 GRAPHIC img106467691_0.jpg GRAPHIC 540653
3 GRAPHIC img106467691_1.jpg GRAPHIC 375821
  Complete submission text file 0000950170-24-046022.txt   1292823
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39208 | Film No.: 24858033
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)